Patents by Inventor Geoffrey Y Akita

Geoffrey Y Akita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of myocardial infarction using TGF-? antagonists
    Patent number: 10633437
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: April 28, 2020
    Assignee: GENZYME CORPORATION
    Inventors: Geoffrey Y. Akita, Scott Lonning, Richard C Gregory, Jr., Amelia B Kudej
  • TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
    Publication number: 20170233465
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Application
    Filed: December 12, 2016
    Publication date: August 17, 2017
    Applicant: Genzyme Corporation
    Inventors: Geoffrey Y. AKITA, Scott Lonning, Richard C. Gregory, JR., Amelia B. Kudej
  • TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
    Publication number: 20130330352
    Abstract: Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-? to the patient during the acute stage of the myocardial infarction.
    Type: Application
    Filed: September 1, 2011
    Publication date: December 12, 2013
    Applicant: Genzyme Corporation
    Inventors: Geoffrey Y Akita, Richard Gregory, Scott Lonning, Amelia Kudel